As shown in Fig. 2, simultaneous downregulation of both APLP2 and APP did not enhance growth inhibition beyond down-regulation of APLP2 or APP alone, signifying that APLP2 and APP likely act upon the same pathway in pancreatic cancer cell growth (eliminating the scenarios in the bottom half of Table I). Here, APLP2 is linked to familial pancreatic carcinoma.